Encephalomyelitis-West Nile Virus Vaccine
Eastern & Western & Venezuelan, Killed Virus
Indications: For vaccination of healthy horses 4 months of age or older, including pregnant mares, as an aid in the prevention of disease caused by Eastern, Western, and Venezuelan Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus. The duration of immunity against West Nile Virus is at least 12 months.
Administration and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
Precautions: Store at 35-45°F (2-7°C). Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.
This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.
Preservatives: Gentamicin and Amphotericin B.
For Veterinary Use Only
Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.
© 2015 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
US Vet. Lic. No. 124
US Patent No. 8821889.
1 Dose/1 mL
10 Doses/10 mL